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A32-year-oldpremenopausalwomanwithnoprior
pregnancies presented to the Dermatology Mission
Clinic (www.DermatologyMissions.org) with a mass
in her umbilicus. This international volunteer program
was established in St George’s, Grenada, as a collab-
oration with the Ministry of Health to improve
dermatologic care for underserved populations. The
lesion was present for approximately 18 months, with
associated symptoms of pruritus and irritation at the
lesion; she noted that the symptoms were worse after
menstruation. However, she denied dysmenorrhea,
dyspareunia, or dyschezia. The remainder of her
medical history was unremarkable, and she took no
prescription medications. The patient was single,
denied any history of infertility, and had no history
of abdominal or pelvic surgery or trauma. She was
previously referred to a general surgeon, who had
diagnosed keloids approximately 1 year before her
presentation to our dermatology clinic. She was
prescribed betamethasone 0.05% cream, with no
improvement. She subsequently underwent 3 intrale-
sional injections of triamcinolone over the next
2 months, also with no clinical effect. Routine
gynecologic evaluation approximately 1 year before
presentation found incidental uterine leiomyoma, and
she received depot medroxyprogesterone acetate.
During this time, the lesion did not change in
appearance but were no longer painful.
On physical examination, a single hyperpigment-
ed nodule with papillary projections, 1 cm in
diameter, was located in the umbilicus, with a slightrida Atlantic University, Boca Ratona; Dermatology
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FL 33445. E-mail: strassmail2014@gmail.com.violaceous quality and nontender to palpation
(Fig 1). There was no associated blanching with the
lesion.
At the time of her visit to our dermatology clinic, a
presumptive diagnosis of cutaneous umbilical endo-
metriosis was made, and a 3-mm punch biopsy of the
lesion was taken. Histopathologic evaluation found
tall columnar epithelium with basophilic cytoplasm
and basally located oval vesicular nuclei, consistent
with endometrial glands, as well as stroma
containing small spindle cells. These findings were
diagnostic for cutaneous endometriosis. Healing
from the biopsy was unremarkable. She subse-
quently underwent surgical excision of the lesion.
Although she required no prescription medications,
she medicated herself with local herbal tea
remedy made by the ‘‘tree of life’’ bush (Guaiacum
officinale, Lignum vitae).
DISCUSSION
Endometriosis is defined as endometrial tissue
outside of the uterine cavity. Common locations for
endometriosis are the ovaries, fallopian tubes, and
peritoneum. Endometriosis is fairly common,
affecting as many as 1% to 5% of reproductive-age
women.1 This condition classically presents with
a triad of dysmenorrhea, dyspareunia, and dysche-
zia, with cyclical pain that fluctuates with the
patient’s menstrual cycle. Endometriosis is very often
associated with infertility and ectopic pregnancy.1
Spread of endometrial implants to extrapelvic
organs, such as the lung and skin, occurs lessJAAD Case Reports 2016;2:219-21.
2352-5126
 2016 by the American Academy of Dermatology, Inc. Published
by Elsevier, Inc. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
http://dx.doi.org/10.1016/j.jdcr.2016.03.009
219
Fig 1. Darkly hyperpigmented, indurated, and papillo-
matous nodule within the umbilicus.
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patients.1-3
Umbilical endometriosis represents a rare subtype
of cutaneous endometriosis. The greatest risk factor
for developing cutaneous endometriosis is a history
of abdominal or pelvic surgery, including cesarean
section, laparoscopy, amniocentesis, abortion, and
inguinal hernia repairs.2,4-6 In many cases of
umbilical endometriosis, the umbilicus had served
as a site for trocar placement.2,4-7 In addition, cases of
spontaneous umbilical endometriosis are reported. It
is hypothesized that the umbilicus, even in the
absence of iatrogenic manipulation, represents a
physiologic scar that may support the development
of ectopic endometrial tissue. Alternatively, meta-
plasia of local tissue or activation and differentiation
of precursor cells may explain the formation of
endometrial tissue.6,7 It remains to be elucidated if
additional factors in the local tissue environment
participate in the development and propagation of
endometriosis, either by facilitating transport,
encouraging local metaplasia, or driving differentia-
tion in the absence of the postoperative healing
processes.
The diagnosis of cutaneous/umbilical endometri-
osis presents unique challenges. In contrast to other
forms of extrapelvic endometriosis, implants on the
skin are less likely to present with classical symp-
toms. In a recent case series of 15 patients with
umbilical endometriosis, only 20% of the patients
reported pain as a presenting symptom.5 The differ-
ential diagnosis includes umbilical hernia, keloid,
suture granuloma, desmoid tumor, desmoid cyst,
lipoma, papilloma, Sister Joseph’s node, or
abscess.2,5,6,8 Furthermore, in dark-skinned indivi-
duals, pigmented lesions are more likely to mimic
atypical melanoma, pigmented basal cell carcinoma,
and pigmented dermatofibroma sarcoma protuber-
ans (Bednar tumor). Therefore, clinicians must beaware of the additional lesions, such as cutaneous
endometriosis, than may mimic common lesions in
this population.
Surgical excision is typically recommended and
represents the preferred modality for both diagnosis
and treatment. Cutaneous/umbilical endometriosis
tends to be less amendable to medical management,
possibly because of relatively low levels of estrogen
receptors found on cutaneous implants.9 Although
complete excision represents definitive treatment,
there is still a risk of recurrence. Surgical removal
may also be beneficial to patients, as (although
rare) instances of malignant transformation have
been reported.4 Homeopathic therapy with ‘‘tree of
life’’ (G officinale) has been used for several
medical conditions, particularly arthritis and gout.
Several components of this plant, including
polytriterpenoids and saponins, may influence the
disease course through either anti-inflammatory
properties or influence on hormonal balance.10
However, there is very limited high-quality research
regarding the efficacy of treating endometriosis with
G officinale.
Given its wide range of potential clinical pre-
sentations, practitioners in various specialties should
consider the possibility of cutaneous endometriosis.
Dermatologists, rather than surgeons or gynecolo-
gists, may encounter such cases, especially in
patients without pain and other classical symptoms
of endometriosis.5 Furthermore, this case supports
the need for better access to dermatologic care, even
in populations that might not be considered high
risk for skin malignancy or in resource-limited
settings. The availability of practitioners with
dermatological expertise, including an awareness
of variations in presentation of pigmented lesions
that occur in various ethnic backgrounds, played a
crucial role in helping this patient receive an accurate
diagnosis and definitive treatment. Given the risk
of malignant transformation,4 this intervention
has potentially prevented further morbidity and
mortality.
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